Cubist Systematic Strategies’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,683
| Closed | -$646K | – | 3842 |
|
|
2023
Q4 | $646K | Buy |
+4,683
| New | +$616K | ﹤0.01% | 2372 |
|
|
2023
Q2 | – | Sell |
-3,891
| Closed | -$536K | – | 3671 |
|
|
2023
Q1 | $550K | Sell |
3,891
-5,772
| -60% | -$826K | ﹤0.01% | 2611 |
|
|
2022
Q4 | $1.51M | Sell |
9,663
-46,843
| -83% | -$6.73M | 0.01% | 2089 |
|
|
2022
Q3 | $6.93M | Buy |
56,506
+19,579
| +53% | +$2.58M | 0.04% | 771 |
|
|
2022
Q2 | $4.91M | Buy |
36,927
+11,010
| +42% | +$1.5M | 0.03% | 999 |
|
|
2022
Q1 | $3.55M | Buy |
25,917
+15,258
| +143% | +$2.13M | 0.03% | 1009 |
|
|
2021
Q4 | $1.84M | Sell |
10,659
-103,595
| -91% | -$15.8M | 0.02% | 1444 |
|
|
2021
Q3 | $16.6M | Buy |
114,254
+54,288
| +91% | +$7.94M | 0.21% | 62 |
|
|
2021
Q2 | $7.91M | Buy |
59,966
+44,727
| +294% | +$5.86M | 0.09% | 306 |
|
|
2021
Q1 | $1.96M | Sell |
15,239
-41,230
| -73% | -$5.08M | 0.03% | 1053 |
|
|
2020
Q4 | $6.73M | Buy |
56,469
+34,029
| +152% | +$4.15M | 0.09% | 295 |
|
|
2020
Q3 | $2.57M | Sell |
22,440
-3,167
| -12% | -$374K | 0.04% | 750 |
|
|
2020
Q2 | $2.92M | Sell |
25,607
-66,682
| -72% | -$7.07M | 0.05% | 590 |
|
|
2020
Q1 | $7.41M | Buy |
92,289
+83,171
| +912% | +$8.61M | 0.2% | 106 |
|
|
2019
Q4 | $974K | Buy |
9,118
+816
| +10% | +$85.1K | 0.02% | 1175 |
|
|
2019
Q3 | $889K | Sell |
8,302
-13,256
| -61% | -$1.36M | 0.02% | 1029 |
|
|
2019
Q2 | $2.19M | Buy |
+21,558
| New | +$2.07M | 0.04% | 637 |
|
|
2019
Q1 | – | Sell |
-1,423
| Closed | -$118K | – | 2282 |
|
|
2018
Q4 | $118K | Sell |
1,423
-10,250
| -88% | -$961K | 0.01% | 1728 |
|
|
2018
Q3 | $1.26M | Buy |
11,673
+3,155
| +37% | +$346K | 0.07% | 368 |
|
|
2018
Q2 | $936K | Sell |
8,518
-26,132
| -75% | -$2.72M | 0.05% | 512 |
|
|
2018
Q1 | $3.48M | Buy |
34,650
+24,881
| +255% | +$2.55M | 0.2% | 110 |
|
|
2017
Q4 | $962K | Sell |
9,769
-53,139
| -84% | -$5.04M | 0.05% | 502 |
|
|
2017
Q3 | $5.89M | Buy |
62,908
+61,288
| +3,783% | +$6.51M | 0.33% | 28 |
|
|
2017
Q2 | $180K | Buy |
+1,620
| New | +$171K | 0.01% | 1328 |
|
|
2017
Q1 | – | Sell |
-6,138
| Closed | -$564K | – | 1671 |
|
|
2016
Q4 | $564K | Buy |
+6,138
| New | +$529K | 0.05% | 611 |
|
|
2016
Q2 | – | Sell |
-41,995
| Closed | -$3M | – | 1740 |
|
|
2016
Q1 | $3M | Buy |
41,995
+37,901
| +926% | +$2.54M | 0.17% | 122 |
|
|
2015
Q4 | $291K | Sell |
4,094
-6,661
| -62% | -$448K | 0.02% | 1135 |
|
|
2015
Q3 | $661K | Buy |
+10,755
| New | +$752K | 0.03% | 782 |
|
|
2014
Q4 | – | Sell |
-32,538
| Closed | -$1.97M | – | 1917 |
|
|
2014
Q3 | $1.97M | Sell |
32,538
-15,621
| -32% | -$963K | 0.12% | 220 |
|
|
2014
Q2 | $2.83M | Buy |
+48,159
| New | +$2.82M | 0.17% | 152 |
|
Other funds holding DGX
DSA
Cubist Systematic Strategies's DGX Position: Q1 2024 in Review
Cubist Systematic Strategies sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 4,683 shares — an estimated $646K sold.
Cubist Systematic Strategies first reported a position in DGX in Q2 2014 and held it in 30 quarters. The position peaked at $16.6M in Q3 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Cubist Systematic Strategies reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 4,683 Quest Diagnostics shares in Q1 2024, an estimated $646K.
- Cubist Systematic Strategies first reported a position in Quest Diagnostics in Q2 2014 and held it in 30 quarters.
- Cubist Systematic Strategies's Quest Diagnostics position peaked at $16.6M in Q3 2021.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.